Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 155.88%371.9M | -23.58%1.24B | 44.14%564.42M | -56.15%217.03M | 25.55%318.08M | -70.28%145.34M | -8.96%1.63B | 10.84%391.58M | 104.58%494.92M | -27.61%253.35M |
| Net profit before non-cash adjustment | 463.69%753.64M | -36.66%1.45B | -37.49%1.02B | -42.30%146.41M | -15.98%150.8M | -40.71%133.7M | 41.76%2.3B | 440.33%1.64B | 65.06%253.75M | -62.07%179.49M |
| Total adjustment of non-cash items | -428.67%-391.64M | 73.88%-374.79M | 45.79%-759.15M | 2,362.77%146.49M | 1,634.24%118.71M | 442.80%119.16M | -70.80%-1.43B | -757.45%-1.4B | -232.91%-6.47M | 103.09%6.85M |
| -Depreciation and amortization | 73.94%45.02M | -21.51%122.55M | -68.58%31.97M | 65.86%32.94M | 83.10%31.75M | 50.59%25.89M | 146.88%156.14M | 536.52%101.74M | 23.70%19.86M | 8.44%17.34M |
| -Reversal of impairment losses recognized in profit and loss | -84.86%625K | -59.89%147.77M | -70.46%107.05M | 2,051.12%32.78M | 91.82%3.8M | 68.39%4.13M | 131.22%368.39M | 218.97%362.43M | -82.35%1.52M | -10.20%1.98M |
| -Share of associates | -5,499.90%-518.05M | -141.16%-109.14M | -686.62%-62.94M | -31.55%-22.13M | -2,881.99%-14.83M | 76.70%-9.25M | 84.75%-45.26M | 127.27%10.73M | -248.10%-16.82M | 100.24%533K |
| -Disposal profit | --0 | 51.51%-915.81M | 51.51%-915.81M | --0 | --0 | --0 | -163.36%-1.89B | -665.57%-1.89B | --0 | --0 |
| -Net exchange gains and losses | -95.13%190K | -54.13%656K | -79.77%123K | -866.75%-3.14M | -889.66%-229K | 915.10%3.9M | 173.45%1.43M | -79.08%608K | 142.83%409K | 70.59%29K |
| -Other non-cash items | -14.74%80.57M | 1,514.26%379.19M | 530.24%80.45M | 1,026.01%106.03M | 853.17%98.21M | 726.37%94.5M | 42.55%-26.81M | 230.29%12.77M | 18.42%-11.45M | 1.86%-13.04M |
| Changes in working capital | 109.20%9.9M | -78.47%165.2M | 94.36%300.03M | -130.64%-75.87M | -27.54%48.56M | -136.04%-107.52M | -23.97%767.38M | -27.71%154.37M | 197.23%247.65M | -31.57%67.02M |
| -Change in receivables | 27.72%-81.06M | 2.78%-82.79M | 222.71%341M | -351.49%-96.53M | -6.39%-215.1M | -314.89%-112.16M | -124.27%-85.16M | -9.30%105.67M | 3,820.74%38.38M | -540.86%-202.17M |
| -Change in inventory | 43.62%166.55M | -43.54%512.02M | -10.18%185.38M | -70.62%107.72M | -30.27%102.95M | -37.68%115.97M | 13.20%906.79M | 10.80%206.4M | 130.92%366.66M | -31.38%147.64M |
| -Change in payables | 32.10%-75.59M | -58.95%104.88M | -6.26%142.55M | 44.69%-87.06M | 32.22%160.72M | -179.93%-111.33M | -2.53%255.51M | -51.81%152.06M | -105.91%-157.4M | 241.92%121.56M |
| -Changes in other current assets | ---- | -19.09%-368.9M | ---- | ---- | ---- | ---- | 23.47%-309.76M | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | -10.31%4.88M | 21.22M | 5.45M | 4.76M | 5.58M | 5.44M | 0 | 0 | 0 | 0 |
| Tax refund paid | -43.09%-99.76M | -26.04%-205.98M | -45.17%-85.64M | 57.86%-20.17M | -43.06%-30.44M | -97.61%-69.72M | 29.97%-163.43M | 3.10%-59M | 9.31%-47.87M | 42.65%-21.28M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 241.75%277.01M | -27.66%1.06B | 45.60%484.23M | -54.90%201.61M | 26.34%293.21M | -82.14%81.06M | -5.80%1.47B | 13.74%332.58M | 136.36%447.05M | -25.83%232.07M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 47.12%-71.09M | 38.05%-451.01M | 46.11%-64.94M | 78.41%-78.59M | -35.69%-173.06M | -15.92%-134.42M | -339.16%-727.99M | -113.55%-120.51M | -2,108.76%-363.98M | -219.43%-127.54M |
| Net business purchase and sale | ---2.37B | -777.70%-141.35M | -811.85%-146.85M | ---- | ---- | --0 | -101.92%-16.11M | -101.96%-16.11M | ---- | ---- |
| Net investment property transactions | 62.45%-41.64M | 8.54%-940.59M | 28.79%-84.72M | 53.15%-65.84M | -84.23%-679.16M | 72.30%-110.87M | -14.93%-1.03B | 61.53%-118.97M | 24.56%-140.54M | -58.53%-368.65M |
| Net investment product transactions | ---- | --656.87M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | --0 | -84.47%1.35M | --0 | -25.32%-1.35M | --0 | --0 | --8.7M | ---1.77M | ---1.08M |
| Dividends received (cash flow from investment activities) | --0 | 192.25%26.75M | --0 | --0 | --14M | 107.22%12.75M | 35.60%9.15M | --3M | --0 | --0 |
| Interest received (cash flow from investment activities) | 75.32%10.94M | -62.65%16.08M | -76.31%2.37M | -63.46%3.75M | -65.54%3.73M | -48.00%6.24M | 7.49%43.07M | -23.94%9.99M | -0.45%10.27M | 11.91%10.82M |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---190.99M | ---- | ---- | ---- |
| Investing cash flow | -991.97%-2.47B | 56.40%-833.25M | 185.69%364.07M | 72.75%-135.18M | -71.82%-835.84M | 55.09%-226.3M | -985.38%-1.91B | -190.58%-424.89M | -161.16%-496.02M | -98.49%-486.45M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 590.68%2.93B | -2.20%1.27B | -71.44%145.82M | -171.47%-232.96M | 35.20%937.69M | 286.90%424.02M | 1,381.37%1.3B | 335.73%510.61M | 5,533.26%325.94M | 2,874.82%693.55M |
| Increase or decrease of lease financing | 2.77%-562K | -3.73%-2.75M | 32.69%-492K | -30.77%-884K | -21.80%-799K | 2.20%-578K | -43.07%-2.65M | -1,882.93%-731K | 27.23%-676K | 16.33%-656K |
| Issuance fees | ---- | 93.56%-8.88M | ---- | ---- | ---- | ---- | -182.91%-138.04M | ---- | ---- | ---- |
| Cash dividends paid | ---440.49M | 0.00%-275.31M | --0 | --0 | ---- | ---- | -25.00%-275.31M | --0 | --0 | --0 |
| Cash dividends for minorities | 9.00%-354K | 15.45%-5.65M | --0 | 60.88%-1.83M | ---3.43M | -108.02%-389K | -2.55%-6.68M | -2,837.10%-1.82M | -50.06%-4.67M | --0 |
| Interest paid (cash flow from financing activities) | 29.95%-169.43M | 6.30%-856.19M | 22.39%-186.29M | 9.33%-213.29M | 18.21%-214.76M | -37.45%-241.85M | -37.46%-913.79M | 1.57%-240.02M | -30.30%-235.25M | -173.16%-262.57M |
| Net other fund-raising expenses | ---9.01M | -195.92%-40.05M | -122.42%-15.27M | --0 | ---- | ---- | -0.19%-13.53M | 60.34%68.11M | 63.31%-13.76M | ---- |
| Financing cash flow | 1,174.17%2.31B | 283.30%85.74M | -132.86%-65.11M | -727.20%-448.97M | 15.50%418.61M | 126.69%181.2M | 95.58%-46.78M | 248.95%198.1M | 131.38%71.58M | 214.83%362.44M |
| Net cash flow | ||||||||||
| Beginning cash position | 11.78%2.49B | -17.99%2.22B | -17.68%1.72B | 0.03%2.07B | 10.64%2.16B | -17.99%2.22B | 15.33%2.71B | 2.01%2.09B | -9.13%2.07B | -22.81%1.95B |
| Current changes in cash | 218.91%114.66M | 163.46%312.59M | 640.29%783.19M | -1,791.65%-382.53M | -214.77%-124.03M | 104.93%35.95M | -252.82%-492.54M | -83.17%105.8M | 109.88%22.61M | 143.61%108.07M |
| Effect of exchange rate changes | 80.72%-10.41M | -1,166.96%-50.57M | -257.47%-21.88M | -10.49%5.47M | 127.77%19.81M | -1,267.82%-53.97M | -87.53%4.74M | -120.63%-6.12M | -27.58%6.11M | 313.84%8.7M |
| Cash adjustments other than cash changes | ---- | 61.16%-11.31M | ---- | ---- | 10,131.65%13.94M | -67.89%-48.59M | -0.34%-29.12M | --253K | ---289K | ---139K |
| End cash Position | 20.07%2.59B | 12.75%2.47B | 12.75%2.47B | -17.68%1.72B | 0.03%2.07B | 10.64%2.16B | -18.19%2.19B | -18.19%2.19B | 2.01%2.09B | -9.13%2.07B |
| Free cash flow | 485.64%205.9M | -17.75%606.34M | 96.24%417.11M | 48.50%122.59M | 14.98%120.03M | -115.81%-53.39M | -46.94%737.21M | -9.73%212.55M | -52.17%82.56M | -61.74%104.4M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.